Yong-Jun Huh
Director Ejecutivo en GREEN CROSS HOLDINGS CORPORATION .
Fortuna: 19 M $ al 30/04/2024
Perfil
Yong-Jun Huh is currently the Co-Chief Executive Officer, Director & VP at Green Cross Holdings Corp.
and a Director at Artiva Biotherapeutics, Inc. He previously worked as a Director at GREEN CROSS WellBeing Corp.
and as an Executive Vice President at Green Cross Corp.
Huh holds an MBA from the University of Wisconsin and an undergraduate degree from Yonsei University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 02/05/2024 | 1 367 454 ( 2.91% ) | 16 M $ | 30/04/2024 | |
| 31/12/2022 | 300 000 ( 1.69% ) | 2 M $ | 30/04/2024 | |
GC CELL CORPORATION
0.20% | 30/09/2023 | 31 000 ( 0.20% ) | 863 541 $ | 30/04/2024 |
Cargos activos de Yong-Jun Huh
| Empresas | Cargo | Inicio |
|---|---|---|
| GREEN CROSS HOLDINGS CORPORATION | Director Ejecutivo | 01/03/2010 |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Director/Miembro de la Junta | 01/09/2019 |
Antiguos cargos conocidos de Yong-Jun Huh.
| Empresas | Cargo | Fin |
|---|---|---|
| GC BIOPHARMA CORP. | Corporate Officer/Principal | - |
| GREEN CROSS WELLBEING CORPORATION | Director/Miembro de la Junta | - |
Formación de Yong-Jun Huh.
| Yonsei University | Undergraduate Degree |
| University of Wisconsin | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| GREEN CROSS HOLDINGS CORPORATION | Health Technology |
| GREEN CROSS WELLBEING CORPORATION | Health Technology |
| GC BIOPHARMA CORP. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Yong-Jun Huh
